These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19664131)

  • 1. Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma.
    Lee J; Kang WK; Park JO; Park SH; Park YS; Lim HY; Kim J; Kong J; Choi MG; Sohn TS; Noh JH; Bae JM; Kim S; Lim DH; Kim KM; Park CK
    APMIS; 2009 Aug; 117(8):598-606. PubMed ID: 19664131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of phosphorylated signal transducer and activator of transcription 3, epidermal growth factor receptor, p53, and vascular endothelial growth factor receptor 1 expression in resected adenocarcinoma of lung by using tissue microarray.
    Kim HS; Park YH; Lee J; Ahn JS; Kim J; Shim YM; Kim JH; Park K; Han J; Ahn MJ
    Cancer; 2010 Feb; 116(3):676-85. PubMed ID: 20052735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma.
    Jüttner S; Wissmann C; Jöns T; Vieth M; Hertel J; Gretschel S; Schlag PM; Kemmner W; Höcker M
    J Clin Oncol; 2006 Jan; 24(2):228-40. PubMed ID: 16344322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014).
    Grossi F; Spizzo R; Bordo D; Cacitti V; Valent F; Rossetto C; Follador A; Di Terlizzi S; Aita M; Morelli A; Fasola G; Consiglieri C; Ceschia T; Beltrami CA; Belvedere O
    J Thorac Oncol; 2010 Sep; 5(9):1354-60. PubMed ID: 20631638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer.
    Gong W; Wang L; Yao JC; Ajani JA; Wei D; Aldape KD; Xie K; Sawaya R; Huang S
    Clin Cancer Res; 2005 Feb; 11(4):1386-93. PubMed ID: 15746037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome.
    Chatterjee D; Sabo E; Tavares R; Resnick MB
    Clin Cancer Res; 2008 May; 14(10):2994-3001. PubMed ID: 18483365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive activation of signal transducers and activators of transcription 3 correlates with better prognosis, cell proliferation and hypoxia-inducible factor-1α in human gastric cancer.
    Woo S; Lee BL; Yoon J; Cho SJ; Baik TK; Chang MS; Lee HE; Park JW; Kim YH; Kim WH
    Pathobiology; 2011; 78(6):295-301. PubMed ID: 22104200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
    Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS
    Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of SMYD3 was associated with increased STAT3 activation in gastric cancer.
    Liu Y; Deng J; Luo X; Pan Y; Zhang L; Zhang R; Liang H
    Med Oncol; 2015 Jan; 32(1):404. PubMed ID: 25471787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of transforming growth factor-α, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer.
    Fanelli MF; Chinen LT; Begnami MD; Costa WL; Fregnami JH; Soares FA; Montagnini AL
    Histopathology; 2012 Aug; 61(2):153-61. PubMed ID: 22582975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospho-Stat3 expression and correlation with VEGF, p53, and Bcl-2 in gastric carcinoma using tissue microarray.
    Choi JH; Ahn MJ; Park CK; Han HX; Kwon SJ; Lee YY; Kim IS
    APMIS; 2006 Sep; 114(9):619-25. PubMed ID: 16948814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma.
    Wu ZS; Cheng XW; Wang XN; Song NJ
    Melanoma Res; 2011 Dec; 21(6):483-90. PubMed ID: 21876460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of E2F-1 expression on clinical outcome of gastric adenocarcinoma patients with adjuvant chemoradiation therapy.
    Lee J; Park CK; Park JO; Lim T; Park YS; Lim HY; Lee I; Sohn TS; Noh JH; Heo JS; Kim S; Lim DH; Kim KM; Kang WK
    Clin Cancer Res; 2008 Jan; 14(1):82-8. PubMed ID: 18172256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p-STAT3 in human gastric carcinoma: significant correlation in tumour invasion and prognosis.
    Yakata Y; Nakayama T; Yoshizaki A; Kusaba T; Inoue K; Sekine I
    Int J Oncol; 2007 Feb; 30(2):437-42. PubMed ID: 17203226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression and clinical significance of pSTAT3, VEGF and VEGF-C in pancreatic adenocarcinoma.
    Huang C; Huang R; Chang W; Jiang T; Huang K; Cao J; Sun X; Qiu Z
    Neoplasma; 2012; 59(1):52-61. PubMed ID: 22082308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT-3 correlates with lymph node metastasis and cell survival in gastric cancer.
    Deng JY; Sun D; Liu XY; Pan Y; Liang H
    World J Gastroenterol; 2010 Nov; 16(42):5380-7. PubMed ID: 21072904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase-9 is associated with disease-free survival and overall survival in patients with gastric cancer.
    Chu D; Zhang Z; Li Y; Zheng J; Dong G; Wang W; Ji G
    Int J Cancer; 2011 Aug; 129(4):887-95. PubMed ID: 20957628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer.
    Wei ZW; Xia GK; Wu Y; Chen W; Xiang Z; Schwarz RE; Brekken RA; Awasthi N; He YL; Zhang CH
    Cancer Lett; 2015 Apr; 359(2):335-43. PubMed ID: 25641338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Tumor Vascular Endothelial Growth Factor Expression Is Associated With Poorer Clinical Outcomes in Resected T3 Gastric Adenocarcinoma.
    Lin C; Zhang Z; Xu Y; Wang R; Chen S; Gao J; Wang D; Huang Q; Tu X; Wang L
    Am J Clin Pathol; 2016 Sep; 146(3):278-88. PubMed ID: 27543975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New molecular staging with G-factor supplements TNM classification in gastric cancer: a multicenter collaborative research by the Japan Society for Gastroenterological Carcinogenesis G-Project committee.
    Sawada T; Yashiro M; Sentani K; Oue N; Yasui W; Miyazaki K; Kai K; Fushida S; Fujimura T; Ohira M; Kakeji Y; Natsugoe S; Shirabe K; Nomura S; Shimada Y; Tomita N; Hirakawa K; Maehara Y
    Gastric Cancer; 2015 Jan; 18(1):119-28. PubMed ID: 24488015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.